COVID-19

June 28, 2021

The Pfizer/BioNTech novel coronavirus (COVID-19) vaccination is “highly effective” against the Delta variant, Reuters reported late last

Read More
June 28, 2021

The novel coronavirus (COVID-19) vaccinations producer by Pfizer/BioNTech and Moderna likely produce an immune response that is strong and

Read More
June 25, 2021

Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to novel coronavirus (COVID-19) infection may be the cause of

Read More
June 24, 2021

The novel coronavirus (COVID-19) variant B.1.617.2, also known as the Delta variant, could be dominant in the United States in a few weeks, according

Read More
June 23, 2021

Novel coronavirus (COVID-19) therapies made from combinations of two antibodies are effective against a wide range of variants of the virus,

Read More
June 22, 2021

SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), may have the ability to reactivate dormant tuberculosis (TB), and infection with

Read More
June 21, 2021

Stress, anxiety, and depression during the first few weeks of the novel coronavirus (COVID-19) pandemic were associated with less and lower quality

Read More
June 18, 2021

Exposure to natural spaces during the first novel coronavirus (COVID-19) lockdown in 2020 was beneficial for mental health, according to a new study

Read More